Intercept Pharmaceuticals, Inc.
NASDAQ:ICPT
19 (USD) • At close November 7, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -174.858 | -91.426 | -274.88 | -344.681 | -309.242 | -360.367 | -412.83 | -226.429 | -283.226 | -67.792 | -43.643 | 0 | -15.087 |
| Depreciation & Amortization
| 0.592 | 2.978 | 3.118 | 3.663 | 4.582 | 4.601 | 3.831 | 1.691 | 0.443 | 0.106 | 0.201 | 0.411 | 0.48 |
| Deferred Income Tax
| 0 | -11.776 | 4.241 | 2.38 | 1.306 | 4.429 | 4.987 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 21.889 | 33.888 | 60.85 | 55.982 | 49.914 | 56.968 | 46.205 | 34.189 | 20.127 | 9.446 | 3.349 | 1.866 | 1.693 |
| Change In Working Capital
| 21.917 | -14.417 | 1.999 | 19.331 | -2.847 | 14.646 | 8.439 | 21.345 | 0.699 | 0.178 | -0.592 | 13.895 | -0.071 |
| Accounts Receivables
| 1.479 | -7.141 | -2.646 | -12.35 | -9.193 | -7.375 | -9.126 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0.602 | 0.231 | -0.269 | -1.354 | -3.628 | -1.201 | -2.279 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 23.288 | -4.825 | 13.863 | 56.411 | 10.332 | 29.226 | 19.96 | 32.218 | 6.2 | 3.514 | 2.242 | 0 | -0.124 |
| Other Working Capital
| -3.452 | -2.682 | -8.949 | -23.376 | -0.358 | -6.004 | -0.116 | -10.873 | -5.501 | -3.336 | -2.834 | 13.895 | 0.053 |
| Other Non Cash Items
| 103.68 | 39.114 | 34.646 | 26.712 | 15.573 | 18.75 | 11.914 | 6.302 | 174.219 | 30.056 | 24.936 | -13.565 | -0.672 |
| Operating Cash Flow
| -26.78 | -41.639 | -170.026 | -236.613 | -240.714 | -265.402 | -342.441 | -162.902 | -87.738 | -28.006 | -15.749 | 2.606 | -13.658 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -0.568 | -0.397 | -3.891 | -1.136 | -0.167 | -10.392 | -5.079 | -5.935 | -4.643 | -1.629 | -0.039 | -0.063 | -0.029 |
| Acquisitions Net
| 0 | -71.123 | -166.708 | 187.852 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -552.737 | -349.457 | -330.713 | -603.014 | -436.071 | -231.107 | -511.521 | -640.709 | -204.344 | -125.825 | -65.941 | 0 | 0 |
| Sales Maturities Of Investments
| 451.921 | 420.58 | 497.421 | 415.162 | 388.168 | 529.274 | 456.465 | 257.172 | 112.402 | 57.241 | 1.119 | 0 | 0 |
| Other Investing Activites
| 363.233 | 71.123 | 166.708 | -187.852 | -47.903 | 298.167 | -55.056 | -383.537 | -91.942 | -68.585 | 0.003 | -0.003 | 0.087 |
| Investing Cash Flow
| 261.849 | 70.726 | 162.817 | -188.988 | -48.07 | 287.775 | -60.135 | -389.472 | -96.585 | -70.214 | -64.857 | -0.066 | 0.058 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 227.26 | 261.362 | 0 | 0 | 0 | 0 | 61.169 | 108.5 | 0 | 24.888 |
| Common Stock Repurchased
| -0.557 | -75.825 | -1.994 | -2.158 | -2.18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -267.316 | 1.118 | -0.693 | 457.519 | 263.545 | 2.838 | 414.382 | 565.469 | 190.983 | 66.072 | 108.418 | -0.25 | 24.618 |
| Financing Cash Flow
| -267.316 | 1.118 | -0.693 | 457.519 | 263.545 | 2.838 | 414.382 | 565.469 | 190.983 | 66.072 | 108.418 | -0.25 | 24.618 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| -6.302 | -1.45 | -1.224 | -0.386 | -1.526 | 1.127 | -0.873 | -0.376 | 0 | 0 | -0.007 | -0.006 | -0.029 |
| Net Change In Cash
| -38.549 | 28.755 | -9.126 | 31.532 | -26.765 | 26.338 | 10.933 | 12.719 | 6.66 | -32.148 | 27.804 | 2.284 | 10.989 |
| Cash At End Of Period
| 55.86 | 94.409 | 65.654 | 74.78 | 43.248 | 70.013 | 43.675 | 32.742 | 20.023 | 13.363 | 45.512 | 17.707 | 15.424 |